Global Patent Index - EP 0929309 A1

EP 0929309 A1 19990721 - PHARMACEUTICAL COMPOSITION CONTAINING A MIXED EXTRACT OF PHELLODENDRON AMURENSE RUPRECHT CORTEX AND PATRINIA SCABIOSAEFOLIA FISCH. FOR TREATMENT OF HEPATITIS C

Title (en)

PHARMACEUTICAL COMPOSITION CONTAINING A MIXED EXTRACT OF PHELLODENDRON AMURENSE RUPRECHT CORTEX AND PATRINIA SCABIOSAEFOLIA FISCH. FOR TREATMENT OF HEPATITIS C

Title (de)

ARZNEIMITTEL ZUR BEHANDLUNG DER HEPATITIS, DAS EINEN GEMISCHTEN EXTRAKT AUS PHELLODENDRON AMURENSE RUPRECHT CORTEX UND PATRINIA SCABIOSAEFOLIA FISCH. ENTHÄLT

Title (fr)

COMPOSITION PHARMACEUTIQUE CONTENANT UN EXTRAIT MIXTE D'ECORCE DU PHELLODENDRON AMURENSE RUPRECHT ET DU PATRIANIA SCABIOSAEFOLIA FISCH. SERVANT AU TRAITEMENT DE L'HEPATITE C

Publication

EP 0929309 A1 19990721 (EN)

Application

EP 98935365 A 19980715

Priority

  • KR 9800214 W 19980715
  • KR 19970037815 A 19970807

Abstract (en)

[origin: WO9907399A1] The present invention relates to a pharmaceutical composition for the treatment of hepatitis C which comprises a mixed extract, particularly a mixed aqueous extract or a mixed alcohol extract, of Phellodendron amurense RUPRECHT cortex and Patrinia scabiosaefolia FISCH. as an active ingredient. The mixed extract according to the present invention exhibits an anti-viral activity for hepatitis C and help prevents hepatic cirrhosis orginated from hepatitis C, and further treats hepatitis and hepatic cirrhosis by potentiating the immunological function to inhibit the proliferation of hepatitis C virus and stimulating the proliferation of T helper cells to increase the host immune system. Furthermore, the mixed extract of the present invention is a mixed extract of natural plants characterized in that it does not exhibit any side effects nor drug resistance, and its activity is maintained even when used for a long period.

IPC 1-7

A61K 35/78

IPC 8 full level

A61K 36/00 (2006.01); A61K 31/00 (2006.01); A61K 36/756 (2006.01); A61K 36/84 (2006.01); A61P 1/00 (2006.01); A61P 1/16 (2006.01); A61P 31/00 (2006.01); A61P 31/12 (2006.01)

CPC (source: EP KR US)

A61K 36/756 (2013.01 - EP KR US); A61K 36/84 (2013.01 - EP KR US); A61P 1/00 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61K 2236/33 (2013.01 - KR); A61K 2236/331 (2013.01 - KR); A61K 2300/00 (2013.01 - KR)

C-Set (source: EP US)

  1. A61K 36/756 + A61K 2300/00
  2. A61K 36/84 + A61K 2300/00

Citation (search report)

See references of WO 9907399A1

Designated contracting state (EPC)

DE ES FR GB IT

DOCDB simple family (publication)

WO 9907399 A1 19990218; AU 8464198 A 19990301; BR 9806083 A 19990824; CN 1236319 A 19991124; EP 0929309 A1 19990721; JP 2000503686 A 20000328; KR 19990015612 A 19990305; US 6113909 A 20000905

DOCDB simple family (application)

KR 9800214 W 19980715; AU 8464198 A 19980715; BR 9806083 A 19980715; CN 98801129 A 19980715; EP 98935365 A 19980715; JP 51199399 A 19980715; KR 19970037815 A 19970807; US 28402299 A 19990406